slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 28,801-28,830
Pages 1,349
Rows per page 30
Beat
28,801-28,830 of 40,452
13
Micro Focus | Mergers and Acquisitions Presentation Deck | 29 slidesMicro Focus | Mergers and Acquisitions Presentation Deck | 29 slides · Micro Focus
Conference presentation Investment bank Beat · Evidence & Proof1 hit
14
The slide illustrates the combination of two entities with different accounting standards and fiscal year-ends.Micro Focus | Mergers and Acquisitions Presentation Deck | 29 slides · Micro Focus
Conference presentation Investment bank Beat · Evidence & Proof1 hit
15
The slide illustrates a pro forma combination of two different entities with different accounting standards (IFRS vs US GAAP) and fiscal year-ends.Micro Focus | Mergers and Acquisitions Presentation Deck | 29 slides · Micro Focus
Conference presentation Investment bank Beat · Evidence & Proof1 hit
16
The slide highlights the cash flow performance of two entities with different fiscal year-ends and accounting standards.Micro Focus | Mergers and Acquisitions Presentation Deck | 29 slides · Micro Focus
Conference presentation Investment bank Beat · Evidence & Proof1 hit
24
The image shows the internal components of a Theranos blood-testing device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
25
The image shows the internal mechanics of a diagnostic or sequencing instrument.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
26
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
27
The slide is a frame from a video presentation showing the internal mechanics of a blood testing device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
28
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
29
The slide is a frame from a video demonstration of the Theranos Edison device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
30
This is a system screenshot, not a presentation slide.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
31
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
32
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
33
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
34
The study design follows the CLSI EP05-A3 standard.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
35
References CLSI EP05-A3, a standard for evaluation of precision of quantitative measurement procedures.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
36
The slide includes a disclaimer at the bottom regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
37
The slide references CLSI EP09-A3, a standard for method comparison and bias estimation using patient samples.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
38
The slide includes a disclaimer regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
39
Includes regression equations, r-squared values, sample sizes, median bias, and Allowable Total Error (ATE) metrics for each lipid type.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
40
The slide includes a disclaimer at the bottom regarding FDA clearance.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
41
The slide uses a table to validate performance against industry-standard benchmarks.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
12
The chart illustrates the transition from a complex, fragmented debt structure to a more consolidated one.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · Financials1 hit
13
The slide uses a red arrow to visually emphasize the downward trend in leverage.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · Financials1 hit
14
The chart illustrates a deleveraging schedule for YRC Worldwide.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · Financials1 hit
15
The slide highlights the lack of near-term debt maturities to reassure investors about financial stability.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · Financials1 hit
16
Yellow Corporation | Investor Presentation Deck | 39 slidesYellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · FinancialsLoop · Why Now1 hit
17
OR refers to Operating Ratio. The slide uses a bar chart to show current margins and a table to show the underlying financial components.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · FinancialsLoop · Why Now1 hit
18
The slide uses a numbered list format organized into two columns, each topped with a directional arrow indicating contribution to goals.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · FinancialsLoop · Why Now1 hit
19
The slide uses a 'CapEx Equivalent' metric to combine direct capital expenditure with the capital value of operating leases.Yellow Corporation | Investor Presentation Deck | 39 slides · YRC Worldwide
Pitch deck Investor relations Beat · FinancialsLoop · Why Now1 hit